TrialCancer science2014

Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer.

Yasutsuna Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.